RxDoctor Payments Data

Eric Chau, DO

General Practice · Happy Camp, CANPI 1285970418

Payments from drug & device makers

$354in general payments, 2019–2025

Across 23 payments — averaging $15.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$121
  • Lilly USA, LLC$71
  • Amarin Pharma, Inc.$52
  • Exact Sciences$39
  • Pfizer$24
  • Bayer$20
  • plus $27 from 2 others

What the payments were for

  • Food & beverage$354100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$354 in reported general payments places this provider in the 60th percentile of 12,963 general practice providers in California.

See all general practice providers in California

Medicare billing

Part B allowed, 2024
$793
Medicare patients
57
Services billed
70

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide139$207,693
Trelegy ElliptaFluticasone/Umeclidin/Vilanter84$102,457
JardianceEmpagliflozin60$94,286
TrulicityDulaglutide42$79,324
JanuviaSitagliptin Phosphate48$55,161
KerendiaFinerenone37$54,367
MounjaroTirzepatide25$43,561
LinzessLinaclotide31$38,331
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr29$30,828
InvokanaCanagliflozin20$26,867
XareltoRivaroxaban17$20,981
MyrbetriqMirabegron23$20,686
Breo ElliptaFluticasone/Vilanterol29$20,275
EliquisApixaban11$19,612
Icosapent Ethyl19$12,085

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Arnuity Ellipta$121$164,070168 claims
Lilly USA, LLCTrulicity, Mounjaro$71$122,88567 claims
MerckJanuvia$14$55,16148 claims
BayerKerendia$20$54,36737 claims
PfizerEliquis$24$19,61211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 12,963 general practice providers in California.

Other general practice in Happy Camp

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →